Dr. Joel Raskin, President of Joel Raskin Consulting Inc., brings over 35 years of clinical, academic and global pharmaceutical research and medical affairs experience to his neuroscience consulting practice. Graduating from University of Toronto Medical School in 1981 and Psychiatry in 1986, he was an academic and community psychiatrist before joining Eli Lilly in 1999. During his 20 years at Eli Lilly, Dr. Raskin held various global roles in neuroscience drug development and commercialization, working in mood and anxiety disorders, schizophrenia, chronic pain, Alzheimer’s, and migraine. Dr. Raskin has engaged with governments, regulators, payers, scientific organizations, physicians, educators and advocacy groups. He has published nearly 100 articles, and presented at international conferences and academic institutions. Dr. Raskin was the CMO of MindCure, a psychedelic research company. He is on the scientific review board of the Alzheimer’s Drug Discovery Foundation, served as a scientific advisor to the Weston Family Foundation Brain Institute, and serves as an advisor to drug, device and technology development companies.